Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN

Schlichtiq K, Duerr P, Fromm M, Dörje F (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 137-137

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Martin Fromm Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie Frank Dörje Professur für Molekulare und Klinische Pharmazie

How to cite

APA:

Schlichtiq, K., Duerr, P., Fromm, M., & Dörje, F. (2020). Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN. In ONCOLOGY RESEARCH AND TREATMENT (pp. 137-137). BASEL: KARGER.

MLA:

Schlichtiq, Katja, et al. "Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 137-137.

BibTeX: Download